05.07.2007Advent Venture Partners and Partech International announce Pertinence merger with IntercimPress Release
02.07.2007Biogen Idec and CardioKine partner to develop Lixivaptan, a novel Vasopressin AntagonistPress Release
26.03.2007Advent Venture Partners' portfolio company Algeta raises NOK 250 million in successful offering
Algeta ASA, the Norwegian cancer therapeutics company, today announced the successful closing of its initial public offering.
Press Release01.02.2007Advent Ventures portfolio company Algeta applies for listing on the Oslo Stock Exchange
Algeta ASA, the Norwegian therapeutics company, today announced its application for listing on the Oslo Stock Exchange (Oslo Børs).
Press Release